BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38331059)

  • 1. YAP induces FAK phosphorylation to inhibit gastric cancer cell proliferation via upregulation of HMGB1.
    Jiang Y; Fu L; Liu B; Li F
    Int J Biol Macromol; 2024 Mar; 262(Pt 1):130037. PubMed ID: 38331059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer.
    Shen J; Cao B; Wang Y; Ma C; Zeng Z; Liu L; Li X; Tao D; Gong J; Xie D
    J Exp Clin Cancer Res; 2018 Jul; 37(1):175. PubMed ID: 30055645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
    Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
    Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CBX2 depletion inhibits the proliferation, invasion and migration of gastric cancer cells by inactivating the YAP/β-catenin pathway.
    Zeng M; Li B; Yang L; Guan Q
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
    Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
    J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonreceptor tyrosine phosphatase 14 promotes proliferation and migration through regulating phosphorylation of YAP of Hippo signaling pathway in gastric cancer cells.
    Han X; Sun T; Hong J; Wei R; Dong Y; Huang D; Chen J; Ren X; Zhou H; Tian W; Jia Y
    J Cell Biochem; 2019 Oct; 120(10):17723-17730. PubMed ID: 31168824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.
    Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP
    FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis.
    Chen R; Zhu S; Fan XG; Wang H; Lotze MT; Zeh HJ; Billiar TR; Kang R; Tang D
    Hepatology; 2018 May; 67(5):1823-1841. PubMed ID: 29149457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the relationship of YAP and FAK in hMSCs and osteosarcoma cells: Discrimination of FAK modulation by nuclear YAP depletion or YAP silencing.
    Husari A; Steinberg T; Dieterle MP; Prucker O; Rühe J; Jung B; Tomakidi P
    Cell Signal; 2019 Nov; 63():109382. PubMed ID: 31376525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
    Li T; Guo T; Liu H; Jiang H; Wang Y
    Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer.
    Wang T; Wang D; Sun Y; Zhuang T; Li X; Yang H; Zang Y; Liu Z; Yang P; Zhang C; Cui J; Fu M; Zhang S; Su P; Li Z; Zhu J; Ding Y
    J Exp Clin Cancer Res; 2023 Nov; 42(1):297. PubMed ID: 37950281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori-induced YAP1 nuclear translocation promotes gastric carcinogenesis by enhancing IL-1β expression.
    Wu Y; Shen L; Liang X; Li S; Ma L; Zheng L; Li T; Yu H; Chan H; Chen C; Yu J; Jia J
    Cancer Med; 2019 Jul; 8(8):3965-3980. PubMed ID: 31145543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
    Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
    Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
    Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
    Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHRDL2 promotes cell proliferation by activating the YAP/TAZ signaling pathway in gastric cancer.
    Wang L; Xu W; Mei Y; Wang X; Liu W; Zhu Z; Ni Z
    Free Radic Biol Med; 2022 Nov; 193(Pt 1):158-170. PubMed ID: 36206931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
    Han Y; Tang Z; Zhao Y; Li Q; Wang E
    Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
    Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy.
    Yan H; Qiu C; Sun W; Gu M; Xiao F; Zou J; Zhang L
    Oncol Rep; 2018 Apr; 39(4):1671-1681. PubMed ID: 29436693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.